New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 16, 2014
09:19 EDTISIS, ETRM, WMB, TWTC, DARA, AKS, BLUE, LAYN, WFT, ACMP, LVLT, MDT, SNDK, COV, FIOOn The Fly: Pre-market Movers
HIGHER: Covidien (COV), up 30% after Medtronic (MDT) agreed to acquire the company for $42.9B in cash and stock. Medtronic shares are also up 6% following the news... Fusio-io (FIO), up 24% after SanDisk (SNDK) to acquire the company in all-cash deal valued at approximately $1.1B... tw telecom (TWTC), up 11% after agreeing to be acquired by Level 3 (LVLT) for $40.86 per share. Level 3 shares are up 1% following the announcement... Bluebird bio (BLUE), up 63% after announcing data from a clinical study... Williams Companies (WMB), up 12.3% after Access Midstream (ACMP) confirms Williams' planned acquisition... AK Steel (AKS), up 5% after upgraded at BofA Merrill Lynch... Dara BioSciences (DARA), up 21% after KRN5500 granted orphan drug designation by FDA. LOWER: Weatherford (WFT), down 3% after holders approve change of jurisdiction from Switzerland to Ireland... Layne Christensen (LAYN), down 12% after reporting a greater than expected Q1 loss per share and lower than expected revenues.
News For COV;MDT;FIO;SNDK;TWTC;LVLT;BLUE;WMB;ACMP;AKS;ETRM;WFT;DARA;ISIS;LAYN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
May 19, 2015
10:56 EDTSNDKSanDisk sees enterprise revenue contracting sequentially in Q2
Subscribe for More Information
10:51 EDTBLUEbluebird bio advances as LentiGlobin seen moving faster than expected
The shares of drug developer bluebird bio (BLUE) are surging after the company announced that its LentiGlobin BB305 drug could be granted accelerated approvals in both the U.S. and Europe as a treatment for beta-thalassemia major. In notes to investors earlier today, JPMorgan and Piper were upbeat on the outlook for the drug's development to progress faster than was previously expected. WHAT'S NEW: After meeting with European and U.S. drug regulators, bluebird bio announced that it would participate in the EU's Adaptive Pathways pilot program. The program was launched by the EU in an effort to provide medicine to patients more quickly, the company stated. bluebird bio said that it now believes that it will be able to seek conditional EU approval of LentoGlobin as a treatment for beta-thalassemia major. Following its meeting with the FDA, bluebird said that data for upcoming clinical trials could enable the company to file an application for FDA approval of LentiGlobin. The company added that it had made agreements with the FDA on the general design of two of its upcoming trials. ANALYST REACTION: Piper Jaffray analyst Joshua Schimmer wrote that Blubird seems poised to file for EU approval of LentiGlobin much sooner than anticipated, since EU regulators have indicated that they will enable the company to apply for approval on the basis of only two clinical studies, The FDA is also moving more quickly than Schimmer previously anticipated, the analyst stated. Schimmer said he had previously believed that LentiGlobin would be launched in 2020, but he now thinks the drug could be approved as early as 2017 in the EU and 2018-2019 in the U.S. The analyst kept an Overweight rating on the stock. Similarly, JPMorgan analyst Cory Kasimov wrote that LentiGlobin could be approved before his 2019 estimate, particularly in the EU, where the regulator is not requiring any new trials. LentiGlobin's outlook as a beta-thalassemia major treatment has become more certain as a result of the news, according to the analyst, who continued to recommend buying the shares of bluebird bio. PRICE ACTION: In mid-morning trading, bluebird rose 5.4% to $164.85.
10:49 EDTSNDKSanDisk rallies while presenting at conference
Shares of SanDisk (SNDK) are moving higher while the company is presenting at the J.P. Morgan Global Technology, Media and Telecom Conference. During its presentation, SanDisk management said that 15 nanometer technology is ramping to plan and that it expects "strong" sequential revenue growth in the second half of the year. Shares of SanDisk are up 1.7% to $68.66 in morning trading.
10:46 EDTSNDKSanDisk sees strong sequential revenue growth in 2H
Sees successful completion of embedded qualifications.
10:43 EDTSNDKSanDisk says 15 nanometer technology ramping to plan
Comments from J.P. Morgan Global Technology, Media and Telecom Conference.
08:57 EDTBLUEPiper sees upside to LentiGlobin launch expectations
Piper Jaffray sees upside potential to its expectation that LentiGlobin will launch in 2020 after the bluebird bio this morning provided a regulatory update. Piper believes approval in Europe for treatment of beta-thal major could come as much as three years earlier than expected while approval in the U.S. is likely to be ahead of expectations as well. The firm reiterates an Overweight rating on bluebird with a $186 price target.
08:40 EDTMDTMedtronic sees FY15 revenue $20.3B, may not compare to consensus $28.15B
Subscribe for More Information
08:40 EDTMDTMedtronic sees Q4 adjusted EPS at upper half of $1.08-1.13, consensus $1.10
Subscribe for More Information
08:21 EDTBLUEbluebird bio approval may come sooner than expected, says JPMorgan
JPMorgan analyst Cory Kasimov reiterates an Overweight rating on bluebird bio after the company announced this morning regulatory plans for LentiGlobin in B-thalassemia in the U.S. and Europe. Kasimov says approval could come earlier than the firm's current 2019 estimate with bluebird seeking accelerated approval in both geographies. The analyst recommends remaining a buyer of the stock ahead of the B-thalassemia data in June. Shares of the clinical-stage biotechnology company are up $5.60 to $162 in pre-market trading.
07:31 EDTWFTUBS to hold a conference
Subscribe for More Information
06:05 EDTBLUEbluebird bio discusses potential approval pathways for LentiGlobin BB305
Subscribe for More Information
May 18, 2015
10:10 EDTLVLTHigh option volume stocks
High option volume stocks: ASNA LAZ GTI CBRL ANN ISSI ANET HTS URBN LVLT
10:02 EDTSNDKNAND pricing tracking ahead of expectations, says JPMorgan
JPMorgan said the NAND market is picking up and pricing is tracking ahead of expectations due to restocking momentum. The firm expects NAND market traction heading into 2H driven by new smartphone launches and a recovery in the PC market. Note SanDisk is leveraged to NAND.
09:27 EDTMDTMedtronic announces study results showing CRT system optimizes treatment
Subscribe for More Information
May 17, 2015
12:35 EDTLVLTLevel 3 shares may rise 20% to $66 in a year, Barron's says
Shares of Level 3 could see a 20% upside over the next 12 months and may advance towards $98, Barron's contends in a feature article. Barron's notes that the company has valuable, unused fiberoptic assets that should allow for continued growth as demand trends upwards. Reference Link
May 15, 2015
16:21 EDTWMBStocks end week little changed as data, deals offset bond yield jumps
Stocks ended the week little changed as a number of M&A deals and a few relatively strong economic data points offset worries about rising bond yields. MACRO NEWS: U.S. weekly jobless claims came in better than expected and reached the lowest four-week average level in 15 years... In Europe, the combined GDP of the 19 eurozone countries grew 0.4% in the first quarter, which was a bit weaker than the 0.5% consensus growth forecast but a pickup from the 0.3% growth pace of the final quarter of last year. Of note, all four of the euro zone's largest economies recorded growth in the same quarter for the first time since the first half of 2010... The People's Bank of China reduced its one year interest rate by 0.25%, marking the third time in the last six months that the central bank has cut benchmark rates... Bond yields surged in many of the world's largest economies, raising worries about inflation and putting pressure on stocks in the beginning of the week. COMPANY NEWS: There was a significant amount of M&A activity again this week, with the headliner being Verizon's (VZ) deal to acquire AOL (AOL) for $50 per share in a transaction valued at $4.4B. Danaher (DHR) agreed to buy purification technologies supplier Pall Corporation (PLL) for $127.20 per share in cash. Danaher also announced that it plans to split itself into two publicly traded companies. Energy infrastructure company Williams (WMB) announced a simplification deal to buy its affiliate Williams Partners (WPZ) for $13.9B in an all-stock transaction. Energy exploration company Noble Energy (NBL) agreed to acquire Rosetta Resources (ROSE) in an all-stock deal. Noble is buying Rosetta for $2.1B in stock plus the assumption of Rosetta's net debt of $1.8B... Alibaba (BABA) acquired a 9.3% stake in Zulily (ZU), an e-commerce retailer geared toward women. A person familiar with the matter reportedly told the Wall Street Journal that the Chinese e-commerce giant is not pursuing an outright acquisition of the U.S. company, however... Shares of Netflix (NFLX) jumped Friday and hit a new all-time high after Bloomberg reported that the company is in talks with Wasu Media, a Chinese media company backed by Alibaba Executive Chairman Jack Ma, about forming a partnership to bring its content to China... Nelson Peltz's Trian Fund Management lost its proxy fight with DuPont (DD) as Trian did not succeed in getting its nominees elected to the DuPont board. INDEXES: For the week, the Dow rose 0.45% to 18,272.56, the Nasdaq gained 0.89% to 5,048.29, and the S&P 500 climbed 0.31% to 2,122.73.
13:33 EDTMDTMedtronic: TYRX antibacterial envelope reduces cardiac device infection rates
Subscribe for More Information
12:13 EDTWMBThird Point gives quarterly update on stakes
NEW STAKES: Yum! Brands (YUM), NXP Semiconductors (NXPI), FedEx (FDX), McKesson (MCK), and J M Smucker (SJM). INCREASED STAKES: Actavis (ACT), Roper Technologies (ROP), Delta Air Lines (DAL), and FleetCor Technologies (FLT). DECREASED STAKES: Ally Financial (ALLY), Amgen (AMGN), Phillips 66 (PSX), eBay (EBAY), and Anheuser Busch Inbev SA (BUD). LIQUIDATED STAKES: Alibaba Group (BABA), Citigroup (C), EMC Corporation (EMC), Anglo American (AAL), and Williams Companies (WMB).
08:12 EDTMDTMedtronic Micra TPS meets initial safety, performance measures
Subscribe for More Information
08:03 EDTWMBWilliams places two pipeline projects into service
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use